Agile_Logo-color on white.jpg
Agile Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
March 08, 2017 16:15 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., March 08, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company today reported financial results for the three months...
AGRX NOTICE: Rosen Law Firm Reminds Agile Therapeutics Investors of Important Class Action Deadline – AGRX
February 15, 2017 14:30 ET | The Rosen Law Firm PA
NEW YORK, Feb. 15, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Agile Therapeutics, Inc. securities (NASDAQ:AGRX) from March 9, 2016 through...
Shareholders Foundation
Lawsuit for Investors in Agile Therapeutics Inc (NASDAQ:AGRX) shares announced by Shareholders Foundation
January 30, 2017 09:40 ET | Shareholders Foundation, Inc.
SAN DIEGO, Jan. 30, 2017 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in New Jersey on behalf of certain purchasers of shares of Agile Therapeutics Inc...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Agile Therapeutics, Inc. – AGRX
January 26, 2017 12:16 ET | The Rosen Law Firm PA
NEW YORK, Jan. 26, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Agile Therapeutics, Inc....
Agile_Logo-color on white.jpg
Agile Therapeutics to Present at Biotech Showcase 2017
December 22, 2016 08:00 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) announced today that its Chief Executive Officer, Al Altomari will present at the Biotech Showcase 2017 on...
Agile_Logo-color on white.jpg
Agile Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference
December 22, 2016 07:30 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company, announced today that its Chief Executive Officer, Al...
Agile_Logo-color on white.jpg
Agile Therapeutics, Inc. Announces Full Exercise of Option to Purchase Additional Shares by Underwriters
February 04, 2016 16:10 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile_Logo-color on white.jpg
Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock
January 22, 2016 09:16 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Jan. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile_Logo-color on white.jpg
Agile Therapeutics Announces Completion of Patient Enrollment in Twirla(R) Phase 3 SECURE Clinical Trial
October 19, 2015 16:08 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile_Logo-color on white.jpg
Agile Therapeutics to Participate at FBR Second Annual Healthcare Conference
September 03, 2015 07:45 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...